Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 2nd International Conference on Applied Microbiology and Beneficial Microbes Osaka, Japan .

Day 1 :

Keynote Forum

Giulio Tarro

Foundation T. & L. de Beaumont Bonelli for cancer research, Italy

Keynote: Non-small cell lung (NSCL) cancer search for biomarkers from body fluids to microarrays

Time : 10:00-10:45

Conference Series Applied Microbes 2017 International Conference Keynote Speaker Giulio Tarro photo
Biography:

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

Abstract:

Lung and bronchus cancers are still one of the most common cancers worldwide, and the estimated numbers of new cases and deaths are more than 2.2 and 1.5 million respectively in the United States in 2013. Despite multi-model treatment strategies, including surgery, radiotherapy, chemotherapy and targeted therapy are used, the death rate of lung cancer is still the first leading cause of cancer-related death both in the World and in the America. The 5-year survival rate of lung cancer, predominantly NSCLC, remains as low as 15%. Therefore, improvements in diagnostics (marker associated with different degrees of malignancy and the consequent clinical behaviour of lung tumors) and treatments are urgently needed. Serological markers such as CEA, NSE (neuron-specific enolase) and Cyfra 21-1 are included in the diagnosis and management of lung cancer, but their diagnostic and prognostic value is still being debated and currently the usefulness of tumor associated antigenic biomarkers in the care of patients with lung cancer is limited. Panel of markers has gained widespread acceptance as a diagnostic test, as a prognostic indicator, or as a monitor of the treatment response. In fact, no useful marker for the screening of asymptomatic patients has been identified to date. Ideally, a biomarker should have one strategy of potentially increase both sensitivity and specificity parameters combining several biomarkers into a prognostic panel. Identification of lung cancer-specific biomarkers, together with other noninvasive methods, may allow for much needed further refinement of lung cancer screening to reduce mortality.

Keynote Forum

Lidia Sas Paszt

Research Institute of Horticulture, Poland

Keynote: Beneficial microorganisms improving yield quality of horticultural crops and soil fertility

Time : 11:05-11:50

Conference Series Applied Microbes 2017 International Conference Keynote Speaker Lidia Sas Paszt photo
Biography:

Organization: Department of Soil and Orchard Management, Rhizosphere Laboratory (IO). Experience in research projects and R&D projects: CEAF, CRAFT, EraNet RURAGRI, HortiEnergia, Huntsman, EFSA carried out in collaboration with academic and industrial partners in Poland and abroad. Coordinator and executor of tasks of the research and development project EkoTechProdukt co-financed by the European Commission from the European Regional Development Fund, (2009-2015). Research interests & Achievements in implementation of R&D results and innovative activities: studies in the area of rhizosphere and nutrient management strategies in fruit crops, development of microbial inocula for horticultural production, development of bioproducts for fruit crops. Achievements in the field of industrial property rights: patents, patent applications: development of 6 new microbial consortia and 5 new bioproducts for use in organic fruit growing. Other achievements: member of the WGs of Cost Action 836 (2002-2004), member of the MCs of 3 COST Actions: 631 (2002-2005), E38 (2005-2008), TD 1107 (20012-2016), expert representing Poland in the Programme Committee of the European Commission in FP6 (2002-2006) and in the Programme Committee of the 7th EU Framework Programme (2007-2012), expert of EFSA – European Food Safety Authority (2007-2012), member of the Management Committee and Working Group of COST Action ES 1406 ‘Soil fauna - Key to Soil Organic Matter Dynamics and Modelling (KEYSOM)’ (2015-2018), expert evaluating research projects/reports of the 6th and 7th EU Framework Programmes (2002-2013) and Horizon 2020 (2014-2020).

Abstract:

The Research Institute of Horticulture in Skierniewice is the birthplace of Poland’s first bank of symbiotic mycorrhizal fungi and beneficial bacteria isolated from the rhizosphere of horticultural plants growing in different soil and climatic conditions of Poland. The most effective strains and species of microorganisms are used as components of the newly developed biological preparations: bio-stimulants, composts, and bacterial and mycorrhizal inocula.

The aim of the study was to evaluate the effects of the applied microbial bioproducts on the growth and yield of selected species of horticultural plants. Studies have shown high effectiveness of the beneficial microorganisms collected in SYMBIO BANK in the stimulation of vegetative growth and yielding of horticultural plant species. Some bacterial strains have a protective effect against Botrytis cinerea, Fusarium oxysporum and Verticillium dahliae. The use of synthetic NPK fertilizers has been shown to have a negative effect on the occurrence and activity of beneficial soil microorganisms.

The results of the field experiments demonstrated a positive influence of the organic method of cultivating vegetable and fruit crops with the use of beneficial microorganisms on the occurrence of beneficial groups of microorganisms in the rhizosphere of those plants, including increase in the population of diazotrophs and in the population of spore-forming bacteria. As a result of the application of beneficial microorganisms in organic cultivation significantly higher yields of the tested vegetable and fruit species were achieved, with better storage and processing qualities compared to conventional production. Widespread use of the innovative bioproducts in organic cultivation of horticultural crops will improve the quality of yield and soil fertility.

Keynote Forum

Ceri L Gwyther

Open University, UK

Keynote: Improved testing for the pathogenic fungi Aspergillus fumigatus

Time : 11:50-12:35

Conference Series Applied Microbes 2017 International Conference Keynote Speaker Ceri L Gwyther photo
Biography:

Ceri Gwyther has been working in environmental science since 1998 when she first studied Environmental Biology. Despite a brief sojourn into Conservation and Land Management (MSc), Ceri found that she was drawn to saving the planet by understanding life on the micro-scale. In 2008, Ceri returned to education and completed her PhD in bioreduction (the biodegradation of animal carcasses in a sealed unit containing mesophilic, aerated water by utilising the intrinsic microbial communities) which offered the perfect opportunity of blending environmental science with microbiology. Whilst finishing up her PhD she was offered a postdoctoral position where she was asked to investigate the efficacy of UV disinfection on the destruction of faecal bacteria in wastewater. When an  opportunity arose at the Open University, Ceri chose to pursue a career as a Project Officer (Microbiology). Ceri’s current research is focussed on the implications of bioaerosols on human health

Abstract:

Statement of the Problem: Aspergillus fumigatus (AF) is a major cause of invasive aspergillosis (IA) in immunocompromised people, with mortality rates as high as 70-90% for patients in the most at-risk group. A. fumigatus spores are readily transported by air and are of particular concern in areas where decomposition occurs, e.g. compost sites, farms and waste sites; and in hospitals, where the number of immunosuppressed patients is rapidly increasing. The current protocol for measuring A. fumigatus in bioaerosols is outdated and relies heavily on laboratory staff accurately identifying closely related species and may substantially underestimate the actual numbers of live A. fumigatus in the air. Molecular methods such as quantitative PCR (qPCR) have been used to estimate the numbers of A. fumigatus in bioaerosols. However, this method does not quantify active fungi. The purpose of this study is to provide an improved method of quantifying viable A. fumigatus emitted in bioaerosols. Methodology & Theoretical Orientation: RNA extraction efficiency from A. fumigatus Af293 was examined using different bead-beating techniques followed by TRIzol extraction. Primers were designed to target the 1-3 β-glucan synthase catalytic subunit, fksP. Standards were prepared using RT-qPCR products of RNA from A. fumigatus Af293. The specificity of the assay was tested against other species of Aspergillus, Neosartorya fischeri and Penicillium glabrum, and environmental isolates collected during the study. Findings: Primer specificity was complicated due to the close relationship with N. fischeri, a food-borne fungus phenotypically related to A. fumigatus. However, a two-step reverse transcriptase-qPCR (RT-qPCR) assay was designed using the SYBR Green technology. Conclusion & Significance: Effective treatment of IA depends on the causative agent. Rapidly identifying the most common cause of IA will lead to more targeted and effective treatment and in addition will aid us in identifying contamination in hospital clean rooms

  • Applied Microbiology | Industrial Microbiology | Veterinary Microbiology S
Speaker
Biography:

 Learn-Han Lee, (Ph.D in Molecular Biology), male, a senior lecturer of molecular biology, PI of Novel Bacteria and Drug Discovery Research Group, School of Pharmacy, Monash University Malaysia. Dr. Lee was awarded the prestigious title of Chartered Biologist (CBiol) from the Royal Society of Biology, UK in 2017. Currently, his researches focus on the study of novel bacteria discovery and bio-prospecting of secondary metabolites with anticancer properties. He is the lifetime member of Bergey’s International Society for Microbial Systematics (BISMiS) and a Member of Royal Society of Biology (MRSB, UK). Furthermore he is an associate editor for Frontiers in Microbiology (IF: 4.165) and Frontiers in Pharmacology (IF: 4.418). Now he has 2 patents, and published 2 academic books, 3 book chapters and 75 international articles, with a total citation of 877 and H-index of 17 (Google scholar citation). He has received 19 items of awards from various reputable institutions.

Abstract:

The global burden of cancer continues to surge, mainly due to aging and growth of the world population, on top of cancer-causing lifestyle behaviours including smoking, obesity and lack of exercise. The financial and economic impacts of cancer on health care, patients and society have urged the search for more effective and potent drug to combat and prevent its occurrence. Microorganisms have been an important source of bioactive natural compounds as they provide a sustainable production of bioactive metabolites with a reasonable cost. Members of family Actinobacteria, especially the genus Streptomyces have demonstrated exemplary performance in synthesizing bioactive metabolites. In fact, several chemotherapy drugs in use, e.g. doxorubicin and actinomycin were discovered from Streptomyces. Thus, it is important to continue the search for novel streptomycetes-derived bioactive compounds against cancer cells. Four novel Streptomyces species were identified from the poorly explored mangrove sediment (East Coast, Peninsular Malaysia) using polyphasic approach. These strains (designated as MUSC 26T, MUSC 136T, MUSC 149T and MUSC 164T) have demonstrated significant antioxidant activity and screened for cytotoxic activity against several human cancer cell lines (DU145, CaSki, A549, MCF-7, HT-29, HCT-116, Caco2 and SW480). Among the four strains, MUSC 136T displayed highest cytotoxic activity against colon cancer cell line HCT-116, killing more than half of them at 400 µg/mL, which probably mediated through altering p53 protein and intracellular glutathione levels. Meanwhile, MUSC 164T demonstrated similar cytotoxic effect against HCT-116 with lowest cell survival recorded at 58.2 ± 5.1% after treated with 400 µg/mL of the extract. A deeper investigation into the genome of these streptomycetes revealed potential production of interesting bioactive compounds, which include siderophore desferroxamine. Altogether, these findings suggested that the exploration of new taxa from underexplored area is a good strategy to discover useful bioactive compounds

Juhee Ahn

Kangwon National University, Republic of Korea

Title: Comparative assessment of -lactamases produced by multidrug resistant bacteria

Time : 13:50 -14:20

Speaker
Biography:

Juhee Ahn is interested in the microbial pathogenesis, including the mechanistic studies of antibiotic resistance, bacterial infection, and bacteriophage control. He received his Ph.D. degree majoring in Food Microbiology at the University of Missouri, Columbia, USA and continued his work as a post-doctoral research assistant in Food Microbiology Lab at the University of Missouri (2003-2004) and Food Safety Engineering Lab at the Ohio State University (2004-2006). He was a visiting scholar at the University of Maryland (2012-2013) as well as Zhejiang University (2016-2017). Currently, he is a professor at the department of Medical Biomaterials Engineering, Kangwon National University. South Korea.

Abstract:

The multidrug resistance in K. pneumoniae is primarily mediated by the production of different classes of b-lactamases. The relationship between b-lactamase production and resistance phenotype is essential to understand the resistance mechanisms in K. pneumoniae. However, there is still a lack of information on the phenotypic and genotypic antibiotic resistance profiles in association with the classes of b-lactamases in K. pneumoniae. Therefore, the aim of this study was to evaluate the antibiotic susceptibility and b-lactamase production in ciprofloxacin-induced and clinically-isolated antibiotic-resistant K. pneumoniae strains, based on the interaction between b-lactamases and b-lactamase inhibitors. The antibiotic susceptibility and β-lactamase activity of K. pneumoniae strains, including antibiotic-sensitive K. pneumoniae (KPWT), ciprofloxacin-induced resistant K. pneumoniae (KPCIP), and clinically isolated K. pneumoniae strains (KPCI237, KPCI263, and KPCI272), were determined in the absence and presence of β-lactamase inhibitors (BLI 489, sulbactam, clavulanate, and tazobactam). All strains were highly resistant to ampicillin in the absence of b-lactamase inhibitors (MIC≥512 mg mL-1). In the presence of clavulanate, the MICs of ampicillin and piperacillin against KPWT were decreased by >64-fold and 4-fold, respectively. The resistance of KPCI263 to cefotaxime, ceftazidime, ceftriaxone, and piperacillin were increased in the presence of BLI-489. The antibiotic susceptibilities KPCI237 to b-lactams were not noticeably changed in the presence of β-lactamase inhibitors (clavulanate, sulbactam, and tazobactam). KPWT, KPCIP and KPCI272 were positive for blaSHV, blaAmpC, and blaFOX/MOX, KPCI237 for blaSHV and blaAmpC, and KPCI263 for blaSHV and blaOXA-48. The antibiotic susceptibility corresponded well with the results obtained from dual disc diffusion assay, which was in good agreement with the b-lactamase production. The results provide useful information for understanding the resistance phenotypes in association with b-lactamase production.

Shwu-Jen Liaw

National Taiwan University, Taiwan

Title: The effect of RpoN on swarming in uropathogenic Proteus mirabilis

Time : 14:20 -14:50

Speaker
Biography:

Shwu-Jen Liaw has major research interests in investigating the molecular mechanisms of bacterial pathogenesis and drug resistance. She has discovered several genes and pathways that are associated with swarming and virulence of Proteus mirabilis, a pathogen causing urinary tract infections.

Abstract:

Proteus mirabilis is an important pathogen of the urinary tract, especially in patients with indwelling urinary catheters. Since catheter-associated urinary tract infection is a major health concern due to the complications and recurrence, researches directed at understanding the pathogenesis are warranted. P. mirabilis pathogenesis is closely coupled to swarming. Previously, we found a two component system, QseEF, is involved in the swarming ability and a sRNA GlmY is under the control of QseEF in P. mirabilis. Many studies have shown that the RpoN, a bacterial alternative sigma factor 54, involved in the transcription of nitrogen-related genes, is also associated with motility in pathogenic bacteria. Thus we investigated the role of RpoN in swarming motility in P. mirabilis. Bioinformatic analysis revealed an RpoN binding site located on the glmY-qseEF promoter region in P. mirabilis. We constructed rpoN mutant and performed swarming assay in wild-type and rpoN mutant. We found that the loss of rpoN inhibited swarming motility. The reporter assay and the real-time RT-PCR demonstrated transcription of GlmY is modulated by RpoN. By the real-time RT-PCR, we then showed GlmY modulates mRNA expression of master flagellar regulator flhDC and chemotaxis protein cheA, which corresponds with the finding of swarming defect in glmY mutant. In addition, the real-time RT-PCR data indicated RpoN modulates mRNA expression of glnA, a gene encoding glutamine synthetase (GlnA) essential for synthesis of a swarming signal (glutamine) in P. mirabilis. These data reveal the swarming regulatory network of RpoN, QseEGF, GlmY, FlhDC, CheA and GlnA in P. mirabilis. Altogether, this is the first report about the role of P. mirabilis RpoN in swarming motility and its regulatory mechanism.

Speaker
Biography:

Muinat Olanike Kazeem has expertise in bioprocessing of lignocellulose for biosugars and value added products through catalysis of enzymatic saccharification. Her research involving cellulolytic enzymes majorly from thermophilic bacteria sources employ fermentation and aqueous biphasic system extraction recovery for efficient performance. Her experience in teaching and research in the University of Ilorin, Nigeria and University Putra Malaysia in the field of industrial microbiology and environmental biotechnology is of great contribution to the science. Future research will explore biohydrogen, biocompost, bioethanol and other industrial enzymes

Abstract:

Statement of problem: Caboxymethyl cellulase (CMC) is one of the significant enzyme in biofuel, textile, paper, brewing and animal feed industries, because of its ability to catalyze enzymatic hydrolysis cellulosic material into simple sugars. However, the downstream processing of CMCase from fermentation broth involves tedious conventional chromatographic steps which is time consuming and complicated. Researchers have reported different methods such as gel filtration and ion-exchange chromatography, ammonium sulphate fractionation and chromatography on DEAE-sephadex A-50 and Sephadex G-100 80 and ultrafiltration. However, application in large scale becomes difficult due to high cost, low productivity and multiple purification steps involved; thus, a cost effective strategy for recovery of CMCase is in demand. One possible method to overcome this challenge is aqueous biphasic system extraction (ABSE). The purpose of this study is to examine the effectiveness of applying ABSE involving polyethylene glycol/salt for the partitioning behavior and recovery of CMCase produced from thermophilic Bacillus licheniformis 2D55 fermentation broth. Methodology: The effect of ABS variables of type of salt, PEG molecular weight, crude loading, pH and additional sodium chloride (NaCl) on partitioning behavior of CMCase were investigated. Findings: A 14 % (w/w) crude load , 1 % NaCl, pH 7.0 produced a CMCase recovery yield  (Y) of 88.63 %,  a partition coefficient (K) of 0.21 and purification factor (PFT) of  10.3 from the bottom phase of PEG 8000/sodium citrate ABSE. The hydrophobicity nature of the CMCase surface enhanced the partition and extraction of the CMCase to the salt rich bottom sodium citrate phase. Likewise, impurities undesired proteins were separated to the PEG 8000 rich top phase. The effectiveness of the recovery was confirmed by SDS-PAGE analysis. The study suggest that ABSE may be a potential strategy for industrial purification of CMCase form fermentation broth

Speaker
Biography:

Shih-Yen Chen is currently an attending physician in the Department of Pediatrics, Chang Gung Children’s Hospital and Chang Gung University, Taoyuan, Taiwan. He received his Doctor of Medicine degree from Taipei Medical College, and Doctor of Philosophy degree from Chang Gung University College of Medicine.

Abstract:

Norovirus (NoV) is an emerging enteric pathogen and being recognized as a global health burden as leading viral cause of outbreaks of gastroenteritis worldwide. The rapid transmission of NoV via person-to-person contact makes infection control difficult. Our study is to establish the standardization of viral load in NoV AGE to investigate and correlate clinical features, disease characteristics, viral shedding and transmissibility.

Fecal specimens from recruited children in Chang Gung Children’s Hospital under diagnosis of norovirus gastroenteritis examined by RT-PCR and their clinical features of hospitalization were characterized. Norovirus real time RT-PCR assay with viral copy numbers ((log)/g feces) calculation as viral load were performed. Fisher exact test was used to determine differences between clinical features. The viral load increasing varied from the 3rd day to the 8th day forming an unsmooth plateau feature without peaking. After the 8 th day, the viral load declined and sheded at the 15 th day after illness onset. In regards to correlate viral load with clinical manifestations, we found there is a longer shedding period in patients in 17 febrile patients (16.3 days after disease onset) than in 21 afebrile ones (12.7 days after disease onset) (P=0.03) also a significantly longer shedding period of patients infected by GII.4 Sydney strain (17.6 days after illness onset) then by non- GII.4 Sydney(12.3 days after disease onset) strain norovirus (P <0.01).

In conclusion, the copy numbers based method viral load evaluation provide a more specific and precise way for assessment noroviruses detection, viral shedding, transmissibility, and even clinical correlation.

Speaker
Biography:

Sang Ho Choi works at National Research Laboratory of Molecular Microbiology and Toxicology. He belongs to department of Food Science and Biotechnology, Seoul National University

Abstract:

Bacterial pathogenicity involves numerous virulence factors required for successful survival in host environments as well as invasion and destruction of host tissues. The pathogenic marine bacterium Vibrio vulnificus is a causative agent of food-borne diseases such as gastroenteritis and life-threatening septicemia. It has been reported that expression of V. vulnificus virulence factors is well-coordinated and regulated by sophisticated mechanisms consisting of many global regulatory proteins. Among them, SmcR, a quorum-sensing master regulator and homologue of V. harveyi LuxR, has been identified and found to play a critical role in the regulation of the V. vulnificus virulence factors. The crystal structure of SmcR reveals that SmcR belongs to the TetR family protein possessing putative ligand-binding pockets. To identify the small molecules which bind to and inhibit SmcR, chemical libraries were screened and an SmcR inhibitor exhibiting the most effective SmcR-inhibition activity was selected and named QStatin. The lack of reduction of intracellular levels of SmcR in QStatin-treated V. vulnificus suggested direct binding of the chemical to SmcR. Isothermal titration calorimetric (ITC) and crystallization analyses confirmed the chemical binding of QStatin into the pockets of SmcR. Although no big conformational changes were observed in the crystal structure, binding of QStatin reduced the DNA binding affinity of SmcR, and thereby changed the expressions of SmcR regulon similar to those of SmcR mutants. Accordingly, QStatin significantly inhibits expression of V. vulnificus virulence genes, leading to the decreased mortality of a brine shrimp infected with V. vulnificus. Most interestingly, QStatin attenuates pathogenicity of V. vulnificus, but does not inhibit growth itself at all, unlike existing antibiotics. Consequently, the combined results indicate that QStatin could be a novel lead compound to control QS-mediated pathogenesis of V. vulnificus with the lowest possibility of the appearance of resistant strains.

  • Molecular Microbiology | Cellular Microbiology | Antibiotics and Chemotherapy Clinical and Diagnostic Microbiology | Food and Beverage Microbiology
Speaker
Biography:

Min-Suk Song completed his undergraduate degree, Major in Biology, MSc and PhD degree in Virology in Chungbuk National University College of Medicine. He formerly worked as a Post-Doctoral Research Fellow at St. Jude Children’s Research Hospital. He is currently an Assistant Professor at Chungbuk National University College of Medicine and Research Institute since 2014. His published papers were particularly in the areas of Virology which include pathogenicity, molecular studies and diagnosis of influenza viruses. Recently, he has expanded his research on other viruses such as Enterovirus and MERS-coV. His other research interest includes vaccines and antiviral resistance. His current and future studies aim to contribute in protecting and improving people's health.

Abstract:

Recent increased cases of human infection with emerging infectious viruses such as avian influenza virus (AIV), Middle East Respiratory Syndrome-Corona Virus (MERS-CoV), and Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) are concerns of public health. We developed a simple and rapid detection system using Reverse Transcriptional Loop-mediated Isothermal Amplification (RT-LAMP) method for multiple emerging infectious viruses including MERS-CoV, SFTSV, and multiple influenza viruses infecting human (type B, H1N1, H3N2, H5N1, H5N6, H5N8, and H7N9). In addition, for more feasible application, the RT-LAMP method was optimized with real-time colorimetric visualization and portable diagnostic platform such as pocket warmer. The RT-LAMP detection system performed high sensitivity that can detect up to 0.1 infectious viral genome copies of the viruses within 60 min compared to the conventional RT-PCR based methods which usually take more than 120 min. Moreover, the test has no cross-reactivity with other human infectious viruses including JEV, Dengue, Enterovirus, Zika virus, human coronavirus 229E (229E), human Metapneumovirus (hMPV), human Respiratory Syncytial Virus (hRSV), and other subtypes of influenza viruses including H2, H4, H6, H9, H10, H11, and H12. Thus, this study suggests that our diagnostic assay may provide a rapid, sensitive, cost-effective, multiplex detection system for emerging infectious viruses that can play a crucial role in control of virus outbreak and contribute to the field diagnosis in resource-limited field settings.

Speaker
Biography:

 Takashi Horiuchim his areas of research interest is Genome Dynamics, especially the physiological role in DNA replication fork blocking events in E. coli and S. cerevisiae, successful conversion from the circular genome of E. coli to linear, molecular mechanism of gene amplification of rDNA in yeast and oncogene (drug-resistant gene) in higher eukaryotes, and molecular mechanism of DRCR (Double Rolling Circular Replication) in Herpes Simplex Virus (HSV) and Chloroplast DNA. Dr. Horiuchi got Kihara Prize (2007) from Japan Society of Genetics for “Identification and characterization of DNA replication fork blocking event

Abstract:

It is well established that eukaryote nuclear chromosomes are duplicated from multiple origins of replication. It remains a mystery, however, how genomes of some viruses, such as HSV (Herpes simplex virus) and Baculovirus, or chroloplasts, are replicated. We found recently that (i) double rolling circle replication (DRCR), originally found responsible for replication of yeast 2 micron plasmid DNA, can lead to amplification of oncogenes as well as drug resistance genes, and (ii) that DRCR is highly recombinogenic. In addition, we will present our model, based on these findings, that DRCR is involved in DNA replication of HSV-1, chloroplasts and some mitochondria. The model could explain how DRCR contributes to replication-recombination coupling of HSV, and also how it promote amplicon shortening during gene amplification. HO induced

Speaker
Biography:

Chang-Hwa Song has his expertise in evaluation and passion in improving the health and wellbeing. His work has been focused on the understanding the pathogenesis of tuberculosis based on host immune responses. He has developed his theory for interaction between mycobacteria and host macrophages after years of experience in research, evaluation, teaching and administration in medical school. He published many scientific papers related to endoplasmic reticulum stress response during mycobacterial infection. This approach is responsive to all scientists of tuberculosis and has provided a different way of research

Abstract:

Calreticulin (CRT) is an endoplasmic reticulum luminal calcium-binding chaperone protein. It is associated with the regulation of calcium homeostasis, protein folding and various cellular functions. Many diseases are associated with ER stress including tuberculosis. In this study, we examined the role of Mycobacterium tuberculosis (Mtb) induced ER stress in induction of CRT expression on macrophages. We found that Mtb infection induces CRT production by macrophages and that CRT levels are correlated with the degree of apoptosis. A significant increase in CRT translocation from the cytosol to the plasma membrane after 24 h of infection suggested the importance of CRT localization in the induction of apoptosis during Mtb infection. During the mycobacterial infection, production of reactive oxygen species (ROS) plays crucial roles in induction of ER stress or enhancement of proinflammatory cytokines.   In the present study, we showed that pretreatment with a reactive oxygen species scavenger decreased Mtb-induced CRT expression, leading to the reduction of CHOP and caspase-3 activation. The intracellular survival of Mtb was significantly higher in macrophages transfected with a CRT-specific small interfering RNA than in control cells. The key role of CRT in inducing apoptosis included its interaction with CXCR1 and TNFR1 in Mtb-infected macrophages. The CRT/CXCR1/TNFR1 complex was shown to induce the extrinsic apoptotic pathway during Mtb infection. Collectively, our results suggest that CRT is critical for the intracellular survival of Mtb, via ER-stress-induced apoptosis

Speaker
Biography:

Nguyen completed his PhD in Ghent University about the complexity of the intestinal receptors of Enterotoxigenic E. coli in pigs and the immune response against these pathogens. Nguyen explores the gut and studies the genomic and proteomic of pig gut to search for biomarkers to be used in breeding and prophylaxis. 

Abstract:

Diseases, such as diarrhea and/or edema disease, frequently can occur in pigs shortly after weaning pigs. Main causes are enterotoxigenic (ETEC) or verotoxigenic Escherichia coli (VTEC) expressing F18 fimbriae. Infections lead to considerable economic losses due to mortality, decreased growth rate and cost of medication. F18+ E. coli use their fimbriae to attach to specific receptors on the pig intestinal epithelium and produce enterotoxins (LT, STa and/or STb) and/or verotoxins (VTx2e) leading to diarrhea or edema disease, respectively. Antibiotics are routinely used to combat these infections, but due to the emergence of antimicrobial resistance, there is an urgent need for alternatives. The lab of Immunology discovered that F18+ E. coli specifically interacts with blood group ABH determinants on type 1 core chains (Coddens et al., 2009; PCT/EP2009/062699; INHIBITORS OF F18+ E COLI BINDING). Based on this fundamental discovery, we developed an anti-adhesive therapy. A high dose of the monomeric compounds (e.g. A6-1) could inhibit in vitro the binding of F18+ E. coli to porcine intestinal villi. Multimerization of the monomeric receptor structure could significantly enhance efficacy. The multimer was able to decrease binding in vitro with 66 % at a more than 2,500 times lower concentration than the monomeric sugar. In small intestinal perfused intestinal segments, a 10 times higher dosage than in vitro was able to prevent fluid loss (a measure of diarrhoea) due to inoculation with F18+ STa+STb+ ETEC.  In an in vivo experiment, this dose in feed significantly reduced the duration and height of the faecal excretion of pigs inoculated with an F18+ VTEC strain.

  • Special Session

Session Introduction

Hiroshi Ohrui

Yokohama University of Pharmacy, Japan

Title: An Extremely Excellent Anti-HIV Active Modified Nucleoside, EFdA Focused on its Design

Time : 12:05 -13:05

Speaker
Biography:

Hiroshi Ohrui received Ph.D. degree (1971) from The University of Tokyo. He Joined RIKEN (1966) and moved to Tokyo University (1981). He moved to Yokohama University of Pharmacy (2006). He worked for Dr. J. J. Fox at Sloan- Kettering Institute for Cancer Research (1972-1973) and Dr. J. G. Moffatt at Syntex Research (1973-1974). He received several awards including Inoue Prize for Science (2001), Japan Prize for Agricultural Sciences (2004), The Japan Society for Analytical Chemistry Award (2004), and Japan Academy Prize (2010). His research interests cover organic synthesis, chemical biology and chiral discrimination.  

Abstract:

 

4’-C-Ethynyl-2-fluoro-2’-deoxyadenosine (EFdA) has attracted much attention due to its extremely excellent anti-HIV properties (1. prevent the emergence of resistant HIV mutants, 2. over 400 times more active than AZT and several orders of magnitude more active than the other clinical reverse-transcriptase inhibitor 2’, 3’-dideoxy-nucleoside drugs, 3. very low toxic, 4. long acting, 5. possible use for prophylaxis, and so on).  

EFdA is now under clinical trials as MK-8591 by Merck & Co..                          

For the design of the modified nucleoside which could solve the problems that the clinical drugs have (1. emergence of drug-resistant HIV mutants, 2. adverse effect by drugs, 3. necessity of  taking  quite a few amount of drugs), I have proposed the following working hypotheses . They are (1) the way to prevent the emergence of drug-resistant HIV mutants, (2) the way to decrease the toxicity of modified nucleosides, (3) the way to provide the modified nucleoside with stability to both enzymatic and acidic glycolysis for long acting.

4’-C-substituted-2’-deoxy nucleoside was designed to meet the hypotheses (1), (3), and the two-site modification was performed to meet the hypothesis (2).

The details of the hypotheses and the reasons of the design of 4’-C-substituted-2’-deoxy nucleoside will be presented.

To prevent the deamination of adenine base, fluorine atom was introduced at the 2-position of adenine base.

Finally, EFdA which is modified at the two position(2 and 4’) of the physiologic 2’-deoxyadenosine and has extremely excellent anti-HIV properties has been successfully developed.